http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이충휘,원종혁,옥준영 한국전문물리치료학회 2000 한국전문물리치료학회지 Vol.7 No.1
As in house care is develops and becomes part of the health care delivery system in Korea, it is necessary to quantify the viewpoints of in-patients and outpatients. The purposes of this study are to analyze the utilization of house visits by physical therapist and to investigate the viewpoint of in- and out-patients who had rehabilitation treatment at 3 general hospitals in Wonju, Korea. Two hundred and fifty-eight questionnaires were analyzed and the major findings are as follows: 1. Sixty-five point seven percentage of respondents showed their willingness to utilize house visits by physical therapist if an in house physical therapy program were established. 2. The questionnaire used a Likert-type scale to ask the respondents their viewpoints on in house physical therapy services. Most respondents showed a positive attitude, answering 'I agree'. The findings show that house visits by physical therapists should be introduced as an integral system for the delivery of health care in Korea.
Je Hyuk Chung,Yee Zee Bae,Sung Hyun Kim,Chang Hoon Moon,Jun Young Chung,Hyuk Chan Kwon,Jae Seok Kim,Hyo Jin Kim 대한암학회 2002 Cancer Research and Treatment Vol.34 No.5
Purpose: There is no effective treatment for patientswith advanced gastric cancer having failed to respond tofirst line chemotherapy. The aim of this study was toevaluate the therapeutic activity, and safety, of a FEPregimen in patients with a recurrence of, or metastatic,gastric cancer that had been unresponsive to primarychemotherapy.Materials and Methods: Recurred or metastatic gastriccancer patients that did not respond to a 5-fluorouracilbased regimen were entered into this trial. The patientswere treated with FEP (5-FU, etoposide and cisplatin) assalvage chemotherapy. The treatment regimen was 5-FU(900 mg/m2/day) by continuous infusion for 3 days, etoposide(90 mg/m2/day) on days 1, 2 and 3, and cisplatin(60 mg/m2/day) on day 2. This treatment was repeatedevery 3 weeks.Results: Between December 1997 and October 2001, 28patients were enrolled to the study. The response rate was32.1% (95% CI 15.5~57.8%). The median times to progressionand survival duration were 23~33 weeks, respectively.Among a total of 187 cycles of chemotherapy, the grade3 and 4 hematological toxicities were leukopenia (6.4%),thrombocytopenia (1.6%), and grade 3 non-hematologicalside effects of nausea/vomiting (17.9%).Conclusion: FEP combination chemotherapy seems tobe an effective treatment regimen for gastric cancer assalvage chemotherapy. To confirm these results, largescale of clinical trials will be required. (Cancer Res Treat. 2002;34:382-387)
이준혁(Jun Hyuk Lee),이정은(Jeong Eun Lee),변준기(Jun Gi Byeon),안종빈(Jong-Bin An),김호진(Ho Jin Kim),윤충원(Chung Weon Yun) 한국습지학회 2024 한국습지학회지 Vol.26 No.1
본 연구는 전라남도 고흥군 소재 우량 산림습원 2개소를 대상으로 군락구조를 파악하고 그에따른 천이경향을 구명하고자 수행되었다. 2023년 5월부터 10월까지 Z-M학파의 식물사회학적 방법에 의해 식생조사를 실시하였고 이 자료를 토대로 군락을 분류하여 현존식생도를 작성하였다. 그 결과, 골풀아재비군락, 꽝꽝나무-진퍼리새군락, 오리나무?진퍼리새군락, 진퍼리새군락, 오리나무-소나무군락, 오리나무군락의 총 6개 군락으로 분류되었다. 각 층위별 중요치를 분석한 결과, 골풀아재비군락에서는 절대습지식물인 골풀아재비의 중요치가 높게 나타났으며 나머지 5개 군락의아교목층과 관목층에서는 습지의 극상종인 오리나무, 절대육상식물인 소나무와 꽝꽝나무가, 초본층에서는 중간습원의대표종인 진퍼리새의 중요치가 높게 나타났다. 조사지 내 출현한 모든 관속식물을 습지선호도에 따라 분류한 결과, 골풀아재비군락에서는 절대습지식물의 출현율이 높게 나타났으나 나머지 5개 군락에서는 절대육상식물의 출현율이높게 나타났다. 골풀아재비군락을 제외한 나머지 5개 군락에서는 우량 산림습원을 구성하는 식물 중 육상식물의 출현비율이 높고, 습지가 건조화되는 단계에서 나타나는 진퍼리새가 번성하고 있어 습지의 천이 및 육화가 진행되고 있는것으로 판단되었다. This study was conducted to identify the community structure of two outstanding forest wetlands in Goheung-gun, Jeollanam-do, and to investigate their succession trends. vegetation survey was conducted using the Z-M phytosociological method From May to October, 2023, and based on this data, the Actual vegetation map was created by categorizing communities. This resulted in the classification of six communities. namely, Rhynchospora faberi community, Alnus japonica-Molinia japonica community, Ilex crenata-M. japonica community, M. japonica community, A. japonica-Pinus densiflora community and A. japonica community. The results of each layer's importance value (IV) analysis results indicated that in the R. faberi community, that of R. faberi, an obligate wetland plant, was high. In the subtree and shrub layers of the other five communities, A. japonica, a key species in wetland ecosystems, and Pinus densiflora and I. crenata, both obligate upland plants, exhibited higher IV. In the herb layer, the IV of M. japonica, a representative species of intermediate wetlands, was notably high. The results of classifying all observed plant species in the survey area based on their wetland preference revealed that in the R. faberi community, the occurrence rate of obligate wetland plants was high. However, in the other five communities, the occurrence rate of obligate upland plants was predominantly observed. Excluding the R. faberi community, in the other five communities constituting the outstanding forest wetlands, the occurrence rate of upland plants among the forest plants was high. It was observed that M. japonica which typically appears during the transition of wetlands to drier stages, was flourishing, indicating that the wetland was undergoing vegetation succession and terrestrialization.
( Moon Jae Chung ),( Se Woo Park ),( Seong-hun Kim ),( Chang Min Cho ),( Jun-ho Choi ),( Eun Kwang Choi ),( Tae Hoon Lee ),( Eunae Cho ),( Jun Kyu Lee ),( Tae Jun Song ),( Jae Min Lee ),( Jun Hyuk Son 대한간학회 2021 Gut and Liver Vol.15 No.3
Endoscopic ultrasound (EUS)-guided tissue acquisition of pancreatic solid tumor requires a strict recommendation for its proper use in clinical practice because of its technical difficulty and invasiveness. The Korean Society of Gastrointestinal Endoscopy (KSGE) appointed a task force to draft clinical practice guidelines for EUS-guided tissue acquisition of pancreatic solid tumor. The strength of recommendation and the level of evidence for each statement were graded according to the Minds Handbook for Clinical Practice Guideline Development 2014. The committee, comprising a development panel of 16 endosonographers and an expert on guideline development methodology, developed 12 evidence-based recommendations in eight categories intended to help physicians make evidence-based clinical judgments with regard to the diagnosis of pancreatic solid tumor. This clinical practice guideline discusses EUS-guided sampling in pancreatic solid tumor and makes recommendations on circumstances that warrant its use, technical issues related to maximizing the diagnostic yield (e.g., needle type, needle diameter, adequate number of needle passes, sample obtaining techniques, and methods of specimen processing), adverse events of EUS-guided tissue acquisition, and learning-related issues. This guideline was reviewed by external experts and suggests best practices recommended based on the evidence available at the time of preparation. This guideline may not be applicable for all clinical situations and should be interpreted in light of specific situations and the availability of resources. It will be revised as necessary to cover progress and changes in technology and evidence from clinical practice. (Gut Liver 2021;15:354-374)
Moon Jae Chung,Se Woo Park,Seong-Hun Kim,Chang Min Cho,Jun-Ho Choi,Eun Kwang Choi,Tae Hoon Lee,Eunae Cho,이준규,Tae Jun Song,Jae Min Lee,Jun Hyuk Son,Jin Suk Park,Chi Hyuk Oh,Dong-Ah Park,Jeong-Sik Byeon 대한소화기내시경학회 2021 Clinical Endoscopy Vol.54 No.2
Endoscopic ultrasound (EUS)-guided tissue acquisition of pancreatic solid tumor requires a strict recommendation for its properuse in clinical practice because of its technical difficulty and invasiveness. The Korean Society of Gastrointestinal Endoscopy (KSGE)appointed a Task Force to draft clinical practice guidelines for EUS-guided tissue acquisition of pancreatic solid tumor. The strengthof recommendation and the level of evidence for each statement were graded according to the Minds Handbook for Clinical PracticeGuideline Development 2014. The committee, comprising a development panel of 16 endosonographers and an expert on guidelinedevelopment methodology, developed 12 evidence-based recommendations in 8 categories intended to help physicians makeevidence-based clinical judgments with regard to the diagnosis of pancreatic solid tumor. This clinical practice guideline discussesEUS-guided sampling in pancreatic solid tumor and makes recommendations on circumstances that warrant its use, technical issuesrelated to maximizing the diagnostic yield (e.g., needle type, needle diameter, adequate number of needle passes, sample obtainingtechniques, and methods of specimen processing), adverse events of EUS-guided tissue acquisition, and learning-related issues. Thisguideline was reviewed by external experts and suggests best practices recommended based on the evidence available at the time ofpreparation. This guideline may not be applicable for all clinical situations and should be interpreted in light of specific situations andthe availability of resources. It will be revised as necessary to cover progress and changes in technology and evidence from clinicalpractice.